Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

SHE/002821 stock hub

SHE/002821 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

SHE/002821is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

43.5B

Shenzhen Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

SHE/002821

In the news

Latest news · SHE/002821

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E30.2

P25 17.1P50 24.2P75 37.8

Trailing P/E39.8

P25 23.5P50 41.3P75 83.2

ROE6.3

P25 -0.9P50 4.1P75 8.8

ROIC9.8

P25 -0.5P50 5P75 11.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All SHE/002821 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

236

Groups with data

Currency

CNY

Showing 236 of 236 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	China
Country code	CN
Employees	10,617
Employees Change	1,022%
Employees Change Percent	10.65
Enterprise value	CNY 36B
Exchange	Shenzhen Stock Exchange
Financial currency	CNY
First seen	2026-05-10
Industry	Biotechnology
Isin	CNE100002BZ6
Last refreshed	2026-05-10
Market cap	CNY 43.5B
Price	CNY 124
Price currency	CNY
Rev Per Employee	652,803.38x
Sector	Healthcare
Sic	2834
Symbol	she/002821
Website	https://www.asymchem.com.cn

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.55%
EV Earnings	32.39x
EV/EBIT	30.79x
EV/EBITDA	20.87x
EV/FCF	330.33x
EV/Sales	5.19x
FCF yield	0.25%
Forward P/E	30.19x
P/B ratio	2.42x
P/E ratio	39.76x
P/S ratio	6.27x
PE Ratio10 Y	49.14x
PE Ratio3 Y	26.01x
PE Ratio5 Y	39.38x
PEG ratio	1.55x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	16.85%
EBITDA Margin	24.02%
FCF margin	1.57%
Gross margin	41.3%
Gross Profit	CNY 2.9B
Gross Profit Growth	16.44%
Gross Profit Growth Q	18.23%
Gross Profit Growth3 Y	-16.9%
Gross Profit Growth5 Y	12.91%
Net Income	CNY 1.1B
Net Income Growth	11.75%
Net Income Growth Q	-6.82%
Net Income Growth Years	1%
Net Income Growth3 Y	-31.34%
Net Income Growth5 Y	7.72%
Pretax Margin	18.22%
Profit Margin	16.02%
Profit Per Employee	CNY 104,576
Profitable Years	15
ROA	3.64
Roa5y	6.03
ROCE	6.26
ROE	6.28
Roe5y	12.06
ROIC	9.83
Roic5y	18.72

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	53.09%
Cagr3y	1.04%
Cagr5y	-9.78%
Div CAGR3	-15.14%
Div CAGR5	20.75%
EPS Growth	10.03
EPS Growth Q	-5.62
EPS Growth Years	1
EPS Growth3 Y	-30.77
EPS Growth5 Y	6.12
FCF Growth	-32.18%
FCF Growth Q	-13.67%
FCF Growth3 Y	-65.02%
OCF Growth	22.42%
OCF Growth Q	17.21%
OCF Growth10 Y	27.87%
OCF Growth3 Y	-30.3%
OCF Growth5 Y	18.92%
Revenue Growth	16.56x
Revenue Growth Q	16.91x
Revenue Growth Quarters	2x
Revenue Growth Years	1x
Revenue Growth3 Y	-12.7x
Revenue Growth5 Y	15.05x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CNY 0.35
Assets	CNY 20.7B
Cash	CNY 7.8B
Current Assets	CNY 11.7B
Current Liabilities	CNY 2.1B
Debt	CNY 293.1M
Debt EBITDA	CNY 0.17
Debt Equity	CNY 0.02
Debt FCF	CNY 2.69
Equity	CNY 18B
Interest Coverage	90.91
Liabilities	CNY 2.7B
Long Term Assets	CNY 9B
Long Term Liabilities	CNY 682.6M
Net Cash	CNY 7.5B
Net Cash By Market Cap	CNY 17.27
Net Cash Growth	0.04%
Net Debt EBITDA	CNY -4.51
Net Debt Equity	CNY -0.42
Net Debt FCF	CNY -68.96
Tangible Book Value	CNY 17.4B
Tangible Book Value Per Share	CNY 48
WACC	5.14

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	5.69
Inventory Turnover	2.9
Net Working Capital	CNY 1.9B
Quick ratio	4.74
Working Capital	CNY 9.7B
Working Capital Turnover	CNY 0.72

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-1.56%
Dividend Growth	-38.89%
Dividend Growth Years	0%
Dividend per share	CNY 1.3
Dividend Years	9
Dividend Yield	1.05%
Ex Div Date	2025-06-26
Last Dividend	CNY 1.1
Payout Frequency	Annual
Payout Ratio	35.58%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	53.04%
200-day SMA	103.7
3Y total return	3.16%
50-day SMA	108.8
50-day SMA vs 200-day SMA	50over200
5Y total return	-40.23%
All Time High	380.4
All Time High Change	-67.51%
All Time High Date	2021-11-30
All Time Low	13.09
All Time Low Change	844.37%
All Time Low Date	2016-11-18
ATR	5.29
Beta	0.16
Beta1y	-0.07
Beta2y	0.69
Ch YTD	32.98
High	128.8
High52	131.3
High52 Date	2026-05-07
High52ch	-5.87%
Low	123.5
Low52	79.04
Low52 Date	2025-05-12
Low52ch	56.35%
Ma50ch	13.58%
Price vs 200-day SMA	19.22%
RSI	58.54
RSI Monthly	57.65
RSI Weekly	65.34
Sharpe ratio	1.61x
Sortino ratio	2.89
Total Return	-0.51%
Tr YTD	32.98
Tr1m	3.36%
Tr1w	-0.88%
Tr3m	21.09%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CNY 1.2B
Operating Income Growth	62.13
Operating Income Growth Q	33.03
Operating Income Growth3 Y	-28.9
Operating Income Growth5 Y	7.52
Operating margin	16.85

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	219,489,973%
Net Borrowing	-62,849,986
Shares Insiders	4.34%
Shares Institutions	26.28%
Shares Out	359,723,670
Shares Qo Q	9%
Shares Yo Y	1.56%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CNY 108.9M
Average Volume	9,663,250.3x
Bv Per Share	49.55
CAPEX	CNY -1.4B
Ch1m	3.36
Ch1w	-0.88
Ch1y	51.08
Ch3m	21.09
Ch3y	-2.3
Ch5y	-43.66
Ch6m	29.83
Change	-3.51%
Change From Open	-3.52
Close	128.1
Days Gap	0.01
Depreciation Amortization	496,939,273
Dollar Volume	700,213,177.8
Earnings Date	2026-08-27
EBIT	CNY 1.2B
EBITDA	CNY 1.7B
EPS	CNY 3.11
F Score	5
FCF	CNY 108.9M
FCF EV Yield	0.3x
FCF Per Share	CNY 0.3
Financing CF	-343,866,106
Fiscal Year End	December
Founded	1,998
Goodwill	146,183,447
Graham Number	60.2381
Graham Upside	-51.26
Income Tax	CNY 159.3M
Investing CF	-1,424,115,845
Is Primary Listing	1
Last Earnings Date	2026-03-30
Last Report Date	2026-03-31
Last Split Date	2022-07-21
Last Split Type	Forward
Lynch Fair Value	CNY 24.37
Lynch Upside	-80.28
Ma150	102.8
Ma150ch	20.21%
Ma20	119.8
Ma20ch	3.14%
Net CF	-426,259,706
Next Earnings Date	2026-08-27
Open	128.1
P FCF Ratio	399.2
P OCF Ratio	29.27
Payment Date	2025-06-26
Position In Range	2.43
Ppne	6,794,446,409
Price Date	2026-05-08
Price EBITDA	CNY 26.11
Ptbv Ratio	2.5
Relative Volume	0.59x
Revenue	6,930,813,494x
Tax By Revenue	2.3x
Tax Rate	12.62%
Tr6m	29.83%
Volume	5,666,072
Z Score	9.1

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

SHE/002821 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.1%

$1.30 annual per share

Payout ratio

+35.6%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

+20.7%

0 consecutive years of growth

Total shareholder yield

-0.5%

Next ex-dividend date: 2025-06-26

Performance

SHE/002821 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns SHE/002821?

Insider, institutional, and short-interest positioning.

Institutional ownership

+26.3%

Share of float held by funds and institutions

Insider ownership

+4.3%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+1.6%

Negative means the company is buying back shares.

Technical

SHE/002821 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

58.5

Neutral momentum band

Price vs 200-day MA

+19.2%

50/200-day relationship not available

Beta (5Y)

0.16

Less volatile than the market

Sharpe ratio

1.60

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About SHE/002821

Hub-level FAQ points readers to the deeper analysis pages.

What is the current she/002821 stock rating?

she/002821 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full she/002821 analysis?

The full report lives at /stocks/she/002821/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for she/002821?

The latest report frames she/002821 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the she/002821 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.